Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluconazole | 1 | 2010 | 8 | 0.350 |
Why?
|
| Mycoses | 1 | 2010 | 23 | 0.340 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2010 | 19 | 0.340 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 31 | 0.340 |
Why?
|
| Antifungal Agents | 1 | 2010 | 42 | 0.340 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 184 | 0.130 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 1994 | 8 | 0.110 |
Why?
|
| Rheumatic Fever | 1 | 2012 | 3 | 0.100 |
Why?
|
| Macrolides | 1 | 2012 | 5 | 0.100 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 4 | 0.100 |
Why?
|
| Pharyngitis | 1 | 2012 | 7 | 0.100 |
Why?
|
| Brucella | 1 | 2011 | 3 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2012 | 53 | 0.100 |
Why?
|
| Brucellosis | 1 | 2011 | 4 | 0.100 |
Why?
|
| Bacteremia | 1 | 2011 | 100 | 0.090 |
Why?
|
| Cholestasis | 1 | 2010 | 9 | 0.090 |
Why?
|
| Candidiasis | 1 | 2010 | 22 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 28 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2010 | 187 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 373 | 0.080 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2010 | 175 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2010 | 605 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2010 | 3530 | 0.060 |
Why?
|
| Child | 3 | 2012 | 1407 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2011 | 678 | 0.040 |
Why?
|
| Male | 3 | 2012 | 15143 | 0.040 |
Why?
|
| Female | 3 | 2012 | 15534 | 0.040 |
Why?
|
| Humans | 4 | 2012 | 28054 | 0.040 |
Why?
|
| Adolescent | 2 | 2012 | 2289 | 0.030 |
Why?
|
| Animals | 2 | 2011 | 3824 | 0.030 |
Why?
|
| Spiramycin | 1 | 1994 | 1 | 0.030 |
Why?
|
| Pyrimethamine | 1 | 1994 | 2 | 0.030 |
Why?
|
| Sulfadiazine | 1 | 1994 | 2 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 1994 | 4 | 0.030 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 1994 | 2 | 0.030 |
Why?
|
| Leucovorin | 1 | 1994 | 9 | 0.030 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 1994 | 2 | 0.030 |
Why?
|
| Toxoplasma | 1 | 1994 | 8 | 0.030 |
Why?
|
| Prenatal Care | 1 | 1994 | 9 | 0.030 |
Why?
|
| Neutropenia | 1 | 1994 | 18 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1994 | 165 | 0.030 |
Why?
|
| Calcinosis | 1 | 1994 | 49 | 0.030 |
Why?
|
| Physical Examination | 1 | 1994 | 117 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 1994 | 231 | 0.030 |
Why?
|
| Pilot Projects | 1 | 1994 | 432 | 0.030 |
Why?
|
| Ethylenediamines | 1 | 2012 | 5 | 0.020 |
Why?
|
| Penicillins | 1 | 2012 | 9 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 9 | 0.020 |
Why?
|
| Infant | 1 | 1994 | 566 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2011 | 6 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 14 | 0.020 |
Why?
|
| Mexico | 1 | 2011 | 19 | 0.020 |
Why?
|
| Hepatomegaly | 1 | 2011 | 7 | 0.020 |
Why?
|
| Travel | 1 | 2011 | 14 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 162 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 204 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 318 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1994 | 758 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 664 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1994 | 1181 | 0.020 |
Why?
|
| Chicago | 1 | 2011 | 902 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 990 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1809 | 0.020 |
Why?
|
| Risk Factors | 1 | 2011 | 2371 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3524 | 0.010 |
Why?
|